Stay updated with breaking news from Published March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With 5.6 months of additional follow-up and 78.3% of patients having completed Kisqali® (ribociclib) investigational treatment, the updated analysis shows...
In this narrative medicine essay, a family medicine physician whose daughter was born with a 50% chance of having the Huntingtin gene embraces the joy of the pr
Are you looking for the best vegan fat burner supplement in 2023? This post will provide 7 brands you should try.
Inflammatory breast cancer is an aggressive disease that can be difficult to diagnose, progresses rapidly, & typically has a poor prognosis.
Designed to treat the acne's inflammation, bacteria and follicular hyperkeratinization, IDP-126 has shown significant efficacy compared to standard-care options already on the market.